Personal tools

MCL coexpression mm9:3045: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0003056!6.28e-13!49;UBERON:0004121!9.60e-13!95;UBERON:0000924!9.60e-13!95;UBERON:0006601!9.60e-13!95;UBERON:0002346!2.42e-12!64;UBERON:0003075!2.42e-12!64;UBERON:0007284!2.42e-12!64;UBERON:0010371!6.07e-12!73;UBERON:0000020!2.02e-10!12;UBERON:0001032!2.02e-10!12;UBERON:0004456!2.02e-10!12;UBERON:0000033!2.61e-09!13;UBERON:0001016!6.07e-09!75;UBERON:0010314!1.44e-08!92;UBERON:0001049!2.36e-08!52;UBERON:0005068!2.36e-08!52;UBERON:0006241!2.36e-08!52;UBERON:0007135!2.36e-08!52;UBERON:0000073!3.02e-08!54;UBERON:0001017!4.34e-08!73;UBERON:0000970!5.55e-08!9;UBERON:0000019!5.55e-08!9;UBERON:0000047!5.55e-08!9;UBERON:0010312!5.55e-08!9;UBERON:0004088!5.55e-08!9;UBERON:0002104!5.55e-08!9;UBERON:0001456!5.55e-08!9;UBERON:0003072!5.55e-08!9;UBERON:0004128!5.55e-08!9;UBERON:0003071!5.55e-08!9;UBERON:0005085!6.00e-08!13;UBERON:0003080!1.47e-07!40;UBERON:0001444!2.52e-07!11;UBERON:0002780!3.93e-07!39;UBERON:0001890!3.93e-07!39;UBERON:0006240!3.93e-07!39
|ontology_enrichment_uberon=UBERON:0003056!6.28e-13!49;UBERON:0004121!9.60e-13!95;UBERON:0000924!9.60e-13!95;UBERON:0006601!9.60e-13!95;UBERON:0002346!2.42e-12!64;UBERON:0003075!2.42e-12!64;UBERON:0007284!2.42e-12!64;UBERON:0010371!6.07e-12!73;UBERON:0000020!2.02e-10!12;UBERON:0001032!2.02e-10!12;UBERON:0004456!2.02e-10!12;UBERON:0000033!2.61e-09!13;UBERON:0001016!6.07e-09!75;UBERON:0010314!1.44e-08!92;UBERON:0001049!2.36e-08!52;UBERON:0005068!2.36e-08!52;UBERON:0006241!2.36e-08!52;UBERON:0007135!2.36e-08!52;UBERON:0000073!3.02e-08!54;UBERON:0001017!4.34e-08!73;UBERON:0000970!5.55e-08!9;UBERON:0000019!5.55e-08!9;UBERON:0000047!5.55e-08!9;UBERON:0010312!5.55e-08!9;UBERON:0004088!5.55e-08!9;UBERON:0002104!5.55e-08!9;UBERON:0001456!5.55e-08!9;UBERON:0003072!5.55e-08!9;UBERON:0004128!5.55e-08!9;UBERON:0003071!5.55e-08!9;UBERON:0005085!6.00e-08!13;UBERON:0003080!1.47e-07!40;UBERON:0001444!2.52e-07!11;UBERON:0002780!3.93e-07!39;UBERON:0001890!3.93e-07!39;UBERON:0006240!3.93e-07!39
|tfbs_overrepresentation_for_novel_motifs=0.752782,1.68931,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,1.20566,0.66329,0.870507,0.906098,2.05331,0.933025,0.608226,0,1.14208,0.578045,4.01723,0.876292,0.679146,0.756749,0.932027,0.585919,0.731217,0.963352,1.1146,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,1.40558,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.474221,0.788421,1.05665,0.859154,0.663409,0.646474,1.12346,0.99279,0.971403,1.3966,1.41464,0.940919,0.657156,0.891887,1.08907,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.284975,1.44925,1.882,0.402065,1.05896,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,1.02517,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,3.4439,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.212464,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,3.01409,0.589976,0.38417,0.260379,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.833542
}}
}}

Revision as of 22:19, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr16:37916526..37916560,+p1@Gpr156
Mm9::chr18:46372105..46372115,-p5@Trim36
Mm9::chr18:46372223..46372244,-p4@Trim36


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0004965GABA-B receptor activity0.0197217047134236
GO:0007340acrosome reaction0.0306571960125222
GO:0017156calcium ion-dependent exocytosis0.0306571960125222
GO:0001669acrosome0.0306571960125222
GO:0008067metabotropic glutamate, GABA-B-like receptor activity0.0306571960125222
GO:0016917GABA receptor activity0.0306571960125222
GO:0007338single fertilization0.0357461375881951
GO:0008066glutamate receptor activity0.0357461375881951
GO:0009566fertilization0.0357461375881951



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
pre-chordal neural plate6.28e-1349
ectoderm-derived structure9.60e-1395
ectoderm9.60e-1395
presumptive ectoderm9.60e-1395
neurectoderm2.42e-1264
neural plate2.42e-1264
presumptive neural plate2.42e-1264
ecto-epithelium6.07e-1273
sense organ2.02e-1012
sensory system2.02e-1012
entire sense organ system2.02e-1012
head2.61e-0913
nervous system6.07e-0975
structure with developmental contribution from neural crest1.44e-0892
neural tube2.36e-0852
neural rod2.36e-0852
future spinal cord2.36e-0852
neural keel2.36e-0852
regional part of nervous system3.02e-0854
central nervous system4.34e-0873
eye5.55e-089
camera-type eye5.55e-089
simple eye5.55e-089
immature eye5.55e-089
ocular region5.55e-089
visual system5.55e-089
face5.55e-089
optic cup5.55e-089
optic vesicle5.55e-089
eye primordium5.55e-089
ectodermal placode6.00e-0813
anterior neural tube1.47e-0740
subdivision of head2.52e-0711
regional part of forebrain3.93e-0739
forebrain3.93e-0739
future forebrain3.93e-0739


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}